Insider Transactions in Q1 2024 at Genprex, Inc. (GNPX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 18
2024
|
Mark Stanley Berger Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,319
-21.53%
|
$5,276
$4.4 P/Share
|
|
Feb 18
2024
|
Ryan M. Confer President, CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,126
-10.34%
|
$4,504
$4.4 P/Share
|
|
Feb 18
2024
|
John Rodney Varner Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,642
-9.11%
|
$10,568
$4.4 P/Share
|